Single Specialty
India has emerged as a global leader in CAR-T cell therapy treatment, revolutionizing cancer care with the launch of NexCAR19, the world’s most affordable CAR-T immunotherapy. In late 2023, NexCAR19 became the first CAR T-cell therapy designed and approved in India, marking a historic milestone in advanced CAR-T cell therapy accessibility. The first patient at Tata Memorial Hospital in Mumbai received the breakthrough treatment on June 4, 2021, establishing Mumbai as India’s CAR-T therapy hub.
As of 2024, over 30 hospitals across more than 10 cities in India are offering NexCAR19 CAR-T cell therapy, with top CAR-T therapy hospitals in Delhi, Bangalore, and Chennai providing this life-saving personalized CAR-T therapy procedure. The treatment involves extracting a patient’s T-cells, genetically modifying them to target cancer cells, multiplying them in specialized laboratories, and reinfusing them to fight blood cancer with unprecedented precision and effectiveness. If you or your loved one is battling blood cancer, now is the time to explore this breakthrough solution. Consult with India’s leading CAR-T specialists today and discover how personalized immunotherapy can change the future of your treatment.
Best CAR-T Cell Therapy Hospitals in India – Take the First Step Toward Advanced Cancer Care
Single Specialty
Get expert guidance instantly
Share a few details and our medical team gets back to you within 4 hours with the next steps.
Tell us what you are facing and our medical team will guide you to the right doctors, hospitals and treatment.
Free Review, No Commitment
Free assessment with no pressure to proceed.
Trusted by 100,000+ Patients
Across 125+ countries worldwide
500+ Top Partner Hospitals
Globally accredited medical facilities
5000+ Expert Specialists
Senior doctors across major specialties.
Making quality healthcare accessible to patients worldwide
Everything you need to know about choosing the right hospital, doctor and treatment plan.